Although the precise role of insulin-like growth factor binding protei
ns (IGFBPs) in ovarian physiology remains a matter of study, existing
data suggest a possible antigonadotropic role in the context of follic
ular atresia. Given the above and the need for improved understanding
of the regulation of ovarian IGFBPs, we have set out to explore the ab
ility of IGF-I to modulate IGFBP levels in cultured rat granulosa cell
s. Specifically, granulosa cells (5 x 10(5) viable cells/dish) from im
mature (23-25 days old), estrogen-primed rats were cultured under seru
m-free conditions for 72 h in the absence or presence of IGF-I. At the
conclusion of this incubation period, media samples were collected an
d subjected to Western ligand blotting. Treatment with IGF-I (100 ng/m
l) resulted in a substantial (P < 0.05) increase in the accumulation o
f IGFBP-5, the major 28-29 kDa IGFBP species. Subsequent studies revea
led this effect of IGF-I to be both dose- and time-dependent. A simila
r effect was noted for insulin at dose levels 1-10 mu g/ml at which cr
oss-reaction with the type I IGF receptor (but not with IGFBPs) has be
en amply documented. Des (1-3) IGF-I, a type I receptor-selective liga
nd with markedly reduced avidity for IGFBPs, proved substantially more
potent (as a promoter of IGFBP-5 accumulation) than its native counte
rpart. In contrast, treatment with IGF-II or [Leu(27)]IGF-II, type II
IGF receptor-selective ligands, yielded a more limited effect on IGFBP
5 accumulation in keeping with an overall rank order of potency of des
(1-3) IGF-I > IGF-I > IGF-II greater than or equal to [Leu(27)]IGF-II
. As such, the present findings demonstrate IGF-I to be a potent stimu
latory regulator of granulosa cell-derived IGFBP-5 an effect mediated,
at least in part, via cognate type I IGF receptors. Given that IGF-I
has also previously been shown to effect receptor-independent regulati
on of the accumulation of IGFBP-5 in this same cell type, it must be c
oncluded that the IGF-I-mediated increase in the accumulation of granu
losa cell-derived IGFBP-5 constitutes a complex phenomenon comprising
both receptor-dependent and independent phenomena.